These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32776469)

  • 1. Expert Perspective: An Evidence-Based Approach to Refractory Cutaneous Lupus Erythematosus.
    Borucki R; Werth VP
    Arthritis Rheumatol; 2020 Nov; 72(11):1777-1785. PubMed ID: 32776469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on clinical trials for cutaneous lupus erythematosus.
    Xie L; Lopes Almeida Gomes L; Stone CJ; Faden DF; Werth VP
    J Dermatol; 2024 Jul; 51(7):885-894. PubMed ID: 38491743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of cutaneous lupus erythematosus.
    Hersh AO; Arkin LM; Prahalad S
    Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.
    Tzellos TG; Kouvelas D
    Eur J Clin Pharmacol; 2008 Apr; 64(4):337-41. PubMed ID: 18157526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous lupus erythematosus. Part 2: diagnostics and therapy].
    Kuhn A; Gensch K; Ständer S; Bonsmann G
    Hautarzt; 2006 Apr; 57(4):345-8; quiz 359. PubMed ID: 16547761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
    Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
    J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic approach and treatment of cutaneous lupus erythematosus.
    Sticherling M; Bonsmann G; Kuhn A
    J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cutaneous manifestations of lupus erythematosus: A systematic review.
    Fairley JL; Oon S; Saracino AM; Nikpour M
    Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological therapies in the treatment of cutaneous lupus erythematosus.
    Presto JK; Hejazi EZ; Werth VP
    Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus.
    Cho SK; Vazquez T; Werth VP
    Expert Opin Investig Drugs; 2023 May; 32(5):345-353. PubMed ID: 37148249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
    Rosen JD; Paul S; Maderal A
    Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cutaneous lupus.
    Chang AY; Werth VP
    Curr Rheumatol Rep; 2011 Aug; 13(4):300-7. PubMed ID: 21503694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
    Lim D; Kleitsch J; Werth VP
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lupus erythematosus: diagnosis and treatment.
    Okon LG; Werth VP
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):391-404. PubMed ID: 24238695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
    Zhang YP; Wu J; Han YF; Shi ZR; Wang L
    Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lupus erythematosus: diagnosis and management.
    Fabbri P; Cardinali C; Giomi B; Caproni M
    Am J Clin Dermatol; 2003; 4(7):449-65. PubMed ID: 12814335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
    Chen KL; Krain RL; Werth VP
    F1000Res; 2019; 8():. PubMed ID: 30984372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biological therapeutic approaches to cutaneous lupus erythematosus.
    Tayer-Shifman OE; Rosen CF; Wakani L; Touma Z
    Expert Opin Biol Ther; 2018 Oct; 18(10):1041-1047. PubMed ID: 30118337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Lupus Erythematosus: Progress and Challenges.
    Petty AJ; Floyd L; Henderson C; Nicholas MW
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):12. PubMed ID: 32248318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.